Related Experiment Video
Updated: Apr 12, 2026
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
16.8K
Heart-targeted nanoscale drug delivery systems
Journal of Biomedical Nanotechnology
|May 21, 2015
Summary
Nanocarriers offer promising targeted drug delivery for heart diseases, improving drug deposition in the heart while minimizing side effects. This review explores advances in nanocarrier systems for cardiac therapy.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Nanotechnology
Background:
- Effective drug delivery to the heart is crucial for treating cardiovascular diseases.
- Nanocarriers are emerging as key tools for targeted therapeutic interventions.
- Current treatments face limitations in specificity and off-target effects.
Purpose of the Study:
- To review pathological manifestations, pathogenesis, and therapeutic advances in heart diseases.
- To summarize recent progress in heart-targeted nanoscale drug delivery systems.
- To discuss the clinical trials, market status, and future outlook of these systems.
Main Methods:
- Literature review of pathological and therapeutic aspects of heart diseases.
- Comprehensive summary of various nanocarrier types used for cardiac drug delivery.
- Analysis of clinical trial data and market trends for nanomedicines.
Main Results:
- Nanocarriers like dendrimers, liposomes, and nanoparticles show potential for targeted cardiac drug delivery.
- Successful targeting relies on specific sites, suitable carriers, and effective ligands.
- Targeted delivery aims for localized drug deposition in the heart with reduced systemic toxicity.
Conclusions:
- Nanoscale drug delivery systems represent a significant advancement in cardiovascular therapy.
- Further research and clinical trials are needed to optimize nanocarrier efficacy and safety.
- The future of cardiac treatment may involve personalized nanomedicine approaches.
More Related Videos
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
130
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
130
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
125
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
125
01:23Modified-Release Drug Delivery Systems: Classification
287
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
287
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
129
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
129
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
137
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
137
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
98
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
98